Pancreatic metastasis from mycosis fungoides mimicking primary pancreatic tumor by Ceriolo, Paola et al.
Submit a Manuscript: http://www.wjgnet.com/esps/
Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx
DOI: 10.3748/wjg.v22.i12.3496
World J Gastroenterol  2016 March 28; 22(12): 3496-3501
 ISSN 1007-9327 (print)  ISSN 2219-2840 (online)
© 2016 Baishideng Publishing Group Inc. All rights reserved.
3496 March 28, 2016|Volume 22|Issue 12|WJG|www.wjgnet.com
CASE REPORT
Pancreatic metastasis from mycosis fungoides mimicking 
primary pancreatic tumor
Paola Ceriolo, Valentina Fausti, Elisa Cinotti, Silvia Bonadio, Lizzia Raffaghello, Giovanna Bianchi, 
Giulio Fraternali Orcioni, Roberto Fiocca, Franco Rongioletti, Vito Pistoia, Giacomo Borgonovo
Paola Ceriolo, Course in Paediatric Science, Fetal-Perinatal and 
Paediatric Pathology, University of Genoa, 16132 Genoa, Italy
Paola Ceriolo, Pathology Unit, Istituto Giannina Gaslini, 16132 
Genoa, Italy
Valentina Fausti, Elisa Cinotti, Franco Rongioletti, Section of 
Dermatology, IRCCS AOU San Martino-IST, 16132 Genoa, Italy
Silvia Bonadio, Giulio Fraternali Orcioni, Pathology Unit, 
IRCCS AOU San Martino-IST, 16132 Genoa, Italy
Lizzia Raffaghello, Giovanna Bianchi, Vito Pistoia, Laboratory 
of Oncology, Istituto Giannina Gaslini, 16147 Genoa, Italy
Roberto Fiocca, Pathology Unit, IRCCS AOU San Martino-IST 
and University of Genoa, 16132 Genoa, Italy
Giacomo Borgonovo, Surgery Unit, IRCCS AOU San Martino-
IST and University of Genoa, 16132 Genoa, Italy
Author contributions: All authors contributed to the acquisition 
of data, writing, and revision of this manuscript.
Supported by Cinque per mille e Ricerca Corrente, Ministero 
della Salute to Istituto Giannina Gaslini.
Institutional review board statement: This case report was 
exempt from the Institutional Review Board standards at the 
IRCCS AOU San Martino-IST, Genoa, Italy.
Informed consent statement: The patient involved in this 
study gave his written informed consent authorizing use and 
disclosure of his protected health information.
Conflict-of-interest statement: All the authors have no 
conflicts of interests to declare.
Open-Access: This article is an open-access article which was 
selected by an in-house editor and fully peer-reviewed by external 
reviewers. It is distributed in accordance with the Creative 
Commons Attribution Non Commercial (CC BY-NC 4.0) license, 
which permits others to distribute, remix, adapt, build upon this 
work non-commercially, and license their derivative works on 
different terms, provided the original work is properly cited and 
the use is non-commercial. See: http://creativecommons.org/
licenses/by-nc/4.0/
Correspondence to: Paola Ceriolo, MD, PhD, Course in 
Paediatric Science, Fetal-Perinatal and Paediatric Pathology, 
University of Genoa, 16132 Genoa, Italy. paolettac@gmail.com
Telephone: +39-33-95794156
Fax: +39-0103075010
Received: April 14, 2015
Peer-review started: April 16, 2015
First decision: June 19, 2015
Revised: July 16, 2015
Accepted: September 13, 2015
Article in press: September 14, 2015
Published online: March 28, 2016
Abstract
Mycosis fungoides (MF) is a cutaneous T-cell lymphoma 
that can undergo local progression with possible 
systemic dissemination. We report a case of a patient 
affected by MF with a pancreatic mass that was a 
diagnostic challenge between primitive tumor and 
pancreatic metastasis from MF. Clinical setting findings 
and imaging studies raised the suspicion of a pancreatic 
primary neoplasm. A diagnostic clue was provided by 
the combined histomorphologic/immunohistochemical 
study of pancreatic and cutaneous biopsies, which 
revealed a pancreatic localization of MF. Considering 
the rarity of metastatic localization of MF to the 
pancreas, we next investigated whether chemokine-
chemokine receptor interactions could be involved 
in the phenomenon to provide new insight into the 
possible mechanisms underlying metastatic localization 
of MF to the pancreas. Histological analyses of archival 
pancreatic tissue demonstrated that glucagon-secreting 
cells of the pancreatic islets expressed the CCL27 
chemokine, which may have attracted in our case 
metastatic MF cells expressing the complementary 
receptor CCR10.
Key words: Differential diagnosis; Pancreatic mass; 
Extracutaneous localization; Mycosis fungoides; CCL27, 
CCR10
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Core tip: We believe that this clinical case is very 
interesting both for its rarity (mycosis fungoides 
metastasized to the pancreas) and the complexity of 
the differential diagnosis. In addition, the investigations 
performed provide new insight into the possible 
mechanisms underlying metastatic localization of 
mycosis fungoides to the pancreas. Indeed, histological 
analyses of archival pancreatic tissue demonstrated 
for the first time that glucagon-secreting cells of the 
pancreatic islets express the CCL27 chemokine, which 
may have attracted, in our case, metastatic mycosis 
fungoides cells expressing the complementary receptor 
CCR10.
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INTRODUCTION
Cutaneous T-cell lymphoma (CTCL) includes a group 
of mature (peripheral) T-cell neoplasms characte-
rized by clonal expansion of a mature CD4-positive 
T-cell, putatively belonging to a skin homing subset 
of memory T-cells[1]. According to World Health 
Organization (WHO) criteria, mycosis fungoides (MF) 
is the most common form of CTCL and accounts for 
almost 50% of all primary cutaneous lymphomas[2].
MF is an indolent disease initially limited to the 
skin that undergoes variable cutaneous progression 
with possible systemic dissemination in late stages. 
Although spread of MF to the gastrointestinal tract has 
been described previously, there have been only two 
reports on symptomatic pancreatic involvement[3,4].
Herein, we report a case of MF in anaplastic trans-
formation with pancreatic involvement, mimicking 
primary pancreatic tumor. 
CASE REPORT
A 64-year-old man presented with erythematous 
and nodular lesions on the trunk and extremities 
(erythematous patches on the trunk, red-brown sharply 
demarcated plaques on the extremities, and violaceous 
nodules and exophytic tumor lesions on the occipital 
region, right forearm, and gluteus) (Figure 1A). 
Erythematous skin lesions manifested 6 years before 
admission and followed an indolent course until 1 year 
ago when the full aggressive clinical picture described 
above became apparent. 
Since the lesions were increasing in number and 
unresponsive to the conventional topical therapy, a 
nodule on the right arm of the patient was biopsied. 
The histopathological evaluation led to the diagnosis 
of CTCL, MF-type. The patient was studied with 
abdominal computed tomography (CT) that did not 
show any visceral or lymph node involvement.
Initially, the patient was treated with narrow-
band ultraviolet B therapy (three sessions a week on 
nonconsecutive days, initial dose 0.1 J/cm2, increment 
of the dose 0.1 J/cm2 per session) followed 2 mo later 
by Interferon α2b, 3 million units subcutaneously 
three times a week. Interferon α2b therapy was 
temporarily stopped because of side effects (nausea, 
gastric pyrosis, diarrhea, neutropenia, and anemia) 
and restarted 3 mo later with the addition of oral 
bexarotene (75 mg twice a day for 10 d, subsequently 
three times a day for another 10 d and then four times 
a day for 3 mo) and local radiotherapy of the occipital 
region (36 Gy five times a week for 2 mo). The patient 
responded with partial resolution of the skin lesions, 
especially the nodular ones. Five months later, the 
patient complained of persistent abdominal pain, but 
blood chemistry and abdominal ultrasonography did 
not reveal any abnormality. 
Eight months later, the patient presented with 
jaundice, asthenia, and worsening of abdominal pain.
Blood exams and gastrointestinal ultrasonography 
were initially performed; thereafter, a percutaneous 
ultrasound guided pancreatic core biopsy and a 
cutaneous biopsy were performed for a combined 
histomorphologic and immunohistochemical study. 
In particular, immunohistochemical staining for CD3, 
CD4, CD30, CD45, glucagon, somatostatin, pancreatic 
polypeptide, CCL27, and CCR10 was carried out.
Blood chemistry disclosed abnormal levels of 
amylase (625 U/L; n.v. 5-53 U/L), lipase (9228 U/L; 
n.v. 114-286 U/L), aspartate aminotransferase: 105 
U/L; n.v. 0-40 U/L), alanine aminotransferase (171 U/L; 
n.v. 0-40 U/L), alkaline phosphatase (1539 U/L; n.v. 
98-280 U/L), gamma-glutamyltransferase ( 675 U/L; 
n.v. 11-50), total bilirubin (1.36 mg/dL; n.v. 0.2-1.2 
mg/dL), and direct bilirubin (1 mg/dL; n.v. 0.0-0.4 
mg/dL). These results were indicative of biliary stasis.
Thereafter, gastrointestinal ultrasonography was 
performed showing a mass measuring 70 mm × 48 
mm × 68 mm and involving the head of pancreas with 
peripheric vascularization pattern and Wirsung duct 
dilation. An abdominal CT with contrast agent showed 
an irregular pancreatic mass involving the head of 
the pancreas (Figure 2A, arrow), with dilation of the 
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intrahepatic and the common bile ducts (Figure 2B, 
arrow) in the absence of further pancreatic lesions. 
No involvement of spleen, liver, kidney, or lymph node 
was detected. Imaging studies suggested the presence 
of a pancreatic primary neoplasm. A diagnosis of 
pancreatic adenocarcinoma was unlikely because of 
the homogeneous contrast enhancement and the 
regular margins of the mass. Other potential diagnoses 
included papillary neoplasm, neuroendocrine tumors, 
or lymphoma. Genetic analysis of K-ras, P16, and p53, 
which are highly mutated in pancreatic cancer, was not 
performed. The patient was subjected to percutaneous 
ultrasound guided core biopsy of the pancreatic mass, 
which suggested a metastatic localization of MF but 
did not allow drawing definitive conclusions due to the 
paucity of the material. 
Considering also the extreme rarity of this occurrence, 
the pancreatic needle biopsy was repeated in parallel 
with a cutaneous biopsy to compare the histological 
features of the two specimens. A lymphomatous 
infiltrate consistent with MF was detected in both bioptic 
specimens. 
The cutaneous specimen (Figure 1B and C) revealed 
a dermal nodular infiltrate mainly composed of small-
medium size cells with focal evidence of epidermotropism. 
Neoplastic lymphocytes were positive for CD45 and 
CD4 and showed a heterogeneous expression of CD3. 
A minority (< 25%) of CD30+ larger elements and an 
eosinophilic component were also observed.
The pancreatic parenchyma was completely 
replaced by a neoplastic infiltrate (Figure 1D and E) 
showing features overlapping with those detected in the 
cutaneous specimen.
These findings led us to diagnose peripheral T cell 
lymphoma, MF type. The medium-large CD30+ component 
suggested a tendency toward histological transformation[2]. 
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Figure 1  Macroscopic aspect of cutaneous lesions (A-C) and pancreatic lesion (D and E). Hematoxilyn and eosin staining, magnification × 4 (B), × 10 (D), × 20 (C 
and E).
BA
Figure 2  Abdominal computed tomography with contrast agent.
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the phenomenon. We focused on the CCL27-CCR10 
axis that has a primary role in T cell-mediated skin 
inflammation[14] and cutaneous T cell malignancy[15]. 
Thus, CCR10+ CD4+ T lymphocytes are attracted to 
the skin where the CCR10 ligand CCL27 is secreted by 
keratinocytes of the basal layers of the epidermis in 
normal skin, immobilized on extracellular matrix, and 
displayed on the surface of endothelial cells[14,15].
By immunohistochemical analysis, primary MF 
cells from our patient expressed CCR10, consistent 
with previous reports[1,15]. We hypothesized that 
a subset of MF cells circulating in the peripheral 
blood had upregulated CCR10 and was attracted 
by CCL27 expressed in the pancreas. However, 
CCR10 expression in metastatic MF cells and CCL27 
expression in infiltrated pancreas could not be inves­
tigated due to the minute amount of pancreatic tissue 
obtained from the biopsy. We found no evidence in the 
literature for CCL27 expression in normal pancreas. 
Nonetheless, upon staining of five different archival 
pancreatic tissue samples from three patients with 
pancreatic ductal adenocarcinoma and two patients 
with papillary adenocarcinoma of ampulla (one with 
a concomitant well differentiated neuroendocrine 
tumor), we discovered that the islets of the pancreas, 
but not the exocrine portion, tested positive for CCL27 
expression. Immunohistochemical staining on serial 
sections demonstrated that glucagon-secreting, but 
not somatostatin - or pancreatic polypeptide (PP) - 
secreting, pancreatic endocrine cells expressed CCL27 
(Figure 3). These results point to the attraction of 
DISCUSSION
Extracutaneous localizations of MF are rare and occur 
in long-standing MF with lymph node involvement. The 
literature reports involvement of lungs, spleen, liver, 
kidney, thyroid gland, bone marrow, oral cavity, larynx, 
heart[5], breast[6], central nervous system[7], esophagus[8,9], 
stomach, small intestine[10] and pancreas[3,4].
The diagnosis ante mortem of an extracutaneous 
manifestation of MF is rare and limited to few case 
reports. This is in contrast with autopsy findings, 
showing a high rate of extracutaneous involvement in 
lungs (75%), spleen (60%), liver (53), kidney (44%), 
and pancreas (41%)[11].
To date, only two patients with clinically detectable 
pancreatic metastasis from MF have been reported[3,4]. 
In these cases, intrapancreatic metastases displayed 
an infiltrative pattern without any gross tumor, a feature 
associated with most neoplasms that metastasize to 
the pancreas[4].
Pancreatic involvement is rare not only in MF but 
also in other T-cell cutaneous lymphomas. Only two 
such cases have been reported in association with 
disseminated pagetoid reticulosis[12] and adult T-cell 
leukaemia/lymphoma[13].
Chemokines and their receptors have been associated 
with tumor metastasis, invasion of lymphatic vessels, 
and trafficking of lymphoma cells[1]. Due to the extra-
ordinary rarity of metastatic localization of MF cells to 
the pancreas, we investigated whether chemokine-
chemokine receptor interactions could be involved in 
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Figure 3  Immunohistochemical staining of pancreatic archival tissue sections. A: CCL27; B: Glucagon; C: Somatostati; D: Pancreatic polypeptide. A-D: 
Magnifications × 10.
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CCR10+ malignant lymphocytes by glucagon-secreting 
insulae expressing CCL27 as a potential mechanism 
driving localization of MF cells to the pancreas in our 
patient. To the best of our knowledge, this is the first 
demonstration of CCL27 expression in the pancreas. 
It is important to note, however, that these results 
on CCL27 expression were derived from archival 
pancreatic tissue samples from patients with primary 
malignancies, and the possibility that CCL27 may be 
abnormally upregulated in these conditions cannot be 
excluded.
The CCL27/CCR10 axis is not the only one that has 
been implicated in MF pathogenesis. Recent studies 
have highlighted the pivotal role of the CCL20/CCR6 
axis in cutaneous T cell lymphoma invasiveness and 
metastasis[16]. Thus, our findings may have disclosed 
only one of the possible mechanisms promoting MF 
cell metastasis to the pancreas.
In conclusion, our case posed a clinical diagnostic 
challenge between pancreatic primitive tumor and a 
pancreatic metastasis from MF. In the clinical setting, the 
patient had: (1) jaundice and blood exams indicative 
of bile stasis; and (2) imaging studies raising the 
suspicion of a pancreatic primary neoplasm. A diagnostic 
clue came from the combined histomorphologic and 
immunohistochemical study of pancreatic and cutaneous 
biopsies, which revealed a pancreatic localization of MF. 
Although the prognosis of MF patients that develop 
lymph node or visceral metastasis (stage Ⅳ disease) 
is poor[17], our patient is still alive after a 3 year follow 
up.
COMMENTS
Case characteristics
A 64-year-old man with a previous history of erythematous skins lesions and 
a diagnosis of cutaneous T cell lymphoma, mycosis fungoides (MF) type, 
presented with jaundice, asthenia, and severe abdominal pain.
Clinical diagnosis 
Persistent abdominal pain combined with jaundice suggested a disorder of bile 
ducts or pancreas.
Differential diagnosis
Pancreatic adenocarcinoma, papillary neoplasm, neuroendocrine tumor, 
lymphoma.
Laboratory diagnosis
Abnormally increased levels of amylase, lipase, aspartate aminotransferase, 
alanine aminotransferase, alkaline phosphatase, gamma-glutamyltransferase, 
total bilirubin, and direct bilirubin.
Imaging diagnosis
Gastrointestinal ultrasonography showed a mass involving the head of the 
pancreas and Wirsung duct dilation. An abdominal computed tomography (CT) 
with contrast agent showed an irregular pancreatic mass involving the head of 
the pancreas, with dilation of the intrahepatic and the common bile ducts.
Pathologic diagnosis
Percutaneous biopsy of the pancreatic mass showed a lymphomatous infiltrate 
consistent with metastatic localization of MF. 
Treatment
The patient was subjected to palliative endoscopic retrograde cholan-
giopancreatography.
Related reports
Extracutaneous localizations of MF are rare and occur in long-standing MF 
with lymph node involvement. The literature reports involvement of lungs, 
spleen, liver, kidney, thyroid gland, bone marrow, oral cavity, larynx, heart, 
breast, central nervous system, esophagus, stomach, small intestine, as well as 
pancreas (two cases).
Term explanation
MF is the most common form of cutaneous T-cell lymphoma and accounts for 
almost 50% of all primary cutaneous lymphomas. Primary pancreatic tumors 
may involve the exocrine or the endocrine portion.
Experience and lessons
This case posed a clinical diagnostic challenge between pancreatic primitive 
tumor and a pancreatic metastasis from MF. A diagnostic clue came from the 
combined histomorphologic and immunohistochemical study of pancreatic and 
cutaneous biopsies, which revealed a pancreatic localization of MF.
Peer-review
This manuscript described a rare case with the diagnosis of pancreatic 
metastasis from MF. It further provides interesting study on the mechanism. 
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